🧐We welcome you to read "Fatigue: #Pharmacological and non-pharmacological management in patients with multiple #sclerosis" 👥By Kubra Yeni et al. Read #article here: https://lnkd.in/gcz6RifC
Advanced Neurology (AN)’s Post
More Relevant Posts
-
Discover how emerging oral therapies like TYK-2 inhibition are reshaping psoriasis management. Explore this Frontline Forum interview for expert insights on TYK-2 inhibition and psoriasis. Watch here: https://ow.ly/uM1750QlaPZ
-
-
Discover how emerging oral therapies like TYK-2 inhibition are reshaping psoriasis management. Explore the Frontline Forum interview for expert insights on TYK-2 inhibition and psoriasis. Watch here: https://ow.ly/SoTt50QtcAW
-
-
Consultant Physician and Endocrinologist MBBS (Hons), MRCP(UK), MRCP(Endocrinology), FRCP(Edin), FRCP(London) CCT in GIM, Diabetes & Endocrinology
A quick overview for ADA 2024 SOC ..
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
-
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
-
Watch as Dr. Robert Gabbay MD, PhD gives us an overview of the 2024 Standards of Care in Diabetes- Pharmacologic Approach to Glycemic Treatment. For this and more visit: https://lnkd.in/g3TzxbuT
-
Collaboration in action! Check out our latest case study to see how teamwork made the dream work in delivering a comprehensive First in Human healthy volunteer trial. From safety and tolerability to pharmacokinetics, pharmacodynamics, and cognitive function assessment, this three-part study is a testament to the power of effective stakeholder collaboration. Don't miss out on the details! https://lnkd.in/ed3FgcMZ
Read our case study to discover how multiple stakeholders collaborated effectively to deliver a three-part First in Human healthy volunteer trial, including assessing the safety, tolerability, pharmacokinetics pharmacodynamics and effect on cognitive function. https://lnkd.in/ed3FgcMZ
-
-
Treatment with lipoprotein apheresis (LA) may acutely lower LDL-C concentration by 75-85%. Other possible clinical benefits provided by LA include decreased angina, increased walking distance, plaque stabilization and regression, and regression of xanthomas. http://spr.ly/6048Up8O4
-
-
That's right, 89% of patients over 70 years' old are taking more than 1 drug with a known genetic interaction! PMID: 31454087 Does this impact your loved ones? Our DNA affects how our bodies respond to medicine. 🧬 Not all medications are universally effective: some only work in a minority of individuals, some require adjusted dosages, and others carry the risk of unwanted side effects. Our test helps healthcare professionals to write personalised prescriptions and determine optimal dosages based on an individual's DNA, maximising the likelihood of effectiveness, and minimising the risk of adverse reactions. Reduce the chance that your loved one is taking a medication that isn't working as it should... by ordering a Mantara PGx test today. 🔗 💚 #PrecisionMedicine #MantaraPGX #TestimonialTuesday #HealthTransformation
-
-
Missed Moleculin's recent webcast presentation? Watch the webcast replay for a discussion of the announced plans for the Phase 3 MIRACLE pivotal trial for the treatment of R/R #AcuteMyeloidLeukemia: https://bit.ly/3LPQo8m #AML
-
Stop the medication guessing game! With pharmacogenetics testing, we decode your genetic makeup to determine the most effective medications for you. Say hello to personalized healthcare. #PGX #PharmacogeneticsTesting #DecodingGenetics
-
